ATAD2 and breast neoplasm: Furthermore, ATAD2 (Figure 3D), E2F1 (Figure 3E), and FOXM1 (Figure 3F) were all significantly overexpressed in breast tumors harboring mutant TP53 compared to breast tumors harboring non-mutant TP53.